NULIPHOR

Welcome to the Brand page for “NULIPHOR”, which is offered here for Pharmaceutical preparations for the treatment of and prevention of hyperphosphatemia, chronic kidney disease, hyperlipidemia, diabetes, metabolic syndrome, hypercholesterolemia, urological diseases and disorders, cardiovascular diseases, diseases of the central and peripheral nervous system, gastrointestinal disorders, allergy, obesity, secondary hyperparathyroidism and insulin resistance syndrome;.

Its status is currently believed to be active. Its class is unavailable. “NULIPHOR” is believed to be currently owned by “Mitsubishi Pharma Corporation”.


Owner:
MITSUBISHI PHARMA CORPORATION
Owner Details
Description:
Pharmaceutical preparations for the treatment of and prevention of hyperphosphatemia, chronic kidney disease, hyperlipidemia, diabetes, metabolic syndrome, hypercholesterolemia, urological diseases and disorders, cardiovascular diseases, diseases of the central and peripheral nervous system, gastrointestinal disorders, allergy, obesity, secondary hyperparathyroidism and insulin resistance syndrome;
Categories: PHARMACEUTICAL PREPARATIONS TREATMENT